Hadeel Zaghloul

Hadeel Zaghloul

Auto-generated profile, based on publicly available information

Hadeel Zaghloul

Department of Medicine Weill Cornell Medicine Qatar, Qatar Foundation Doha Qatar

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
HZHadeel Zaghloul
Hadeel Zaghloul
KFKareem Fanous
Kareem Fanous
LALina Ahmed
Lina Ahmed
MAMaryam Arabi
Maryam Arabi
SVSanish Varghese
Sanish Varghese
TAThurayya Arayssi
Thurayya Arayssi
Background: Digital health technology (DHT) plays an increasingly vital role in managing chronic diseases by enabling patients to actively manage their health. These tools have been shown to improve self-management and adherence to medical advice. However, for DHT to be fully effective, patients with chronic conditions must be digitally literate. The eHealth Literacy Scale (eHEALS), an 8‑item tool with scores ranging from 8 to 40, was developed to assess individuals’ perceived ability to find, evaluate, and apply digital health information. Assessing patients’ digital health literacy (DHL) and understanding the factors influencing it are essential for improving the accessibility and usability of health resources. Objective: This study aimed to assess DHL in patients with diabetes mellitus (DM), hypertension, and rheumatoid arthritis (RA) through a systematic review and meta‑analysis using eHEALS. We sought to determine average DHL scores, examine demographic and socioeconomic factors influencing DHL, and explore its impact on disease management to inform future strategies for enhancing DHL and improving chronic disease outcomes. Methods: Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we conducted a systematic review across 7 databases (PubMed, SCOPUS, Embase, ERIC, CINAHL, Library Literature and Information Science Index, and Google Scholar) from inception to August 14, 2022, with an updated search in October 2024. Eligible studies included adults (≥18 years) with DM, hypertension, or RA who reported DHL data using eHEALS (8-40) and were original research published in English. Exclusion criteria included studies involving participants younger than 18 years, reviews, meta‑analyses, studies not addressing the target diseases, or non‑English publications. Study quality was evaluated using the Newcastle‑Ottawa Scale (NOS). Results: Eight studies involving 2527 participants were included. The pooled mean eHEALS score was 27.03 (95% CI 25.08-28.98), indicating high overall DHL. Stratified by disease, scores were higher for DM (27.79) and hypertension (28.48) but lower for RA (24.74). Quality assessment indicated a high standard of included studies. Factors influencing DHL included age, education, employment, and perception of the internet as a health resource. Due to the limited number of studies, meta‑regression analysis could not be performed. Conclusions: DHL is critical for individuals with chronic conditions, empowering them to make informed decisions and manage their health effectively. However, the scarcity of studies limits comprehensive analysis of DHL determinants. While the internet offers abundant health information, unequal DHL and health skills remain barriers. More inclusive research is needed to fully understand DHL’s impact on health outcomes and mitigate disparities, ensuring equitable access to digital health resources and improving disease management.

21 May 2018 in Trials
Verified
Journal Article
Open access
PDF file
STShahrad Taheri
Shahrad Taheri
OCOdette Chagoury
Odette Chagoury
HZHadeel Zaghloul
Hadeel Zaghloul
SESara Elhadad
Sara Elhadad
SASalma Hayder Ahmed
Salma Hayder Ahmed
AAAbdul Badi Abou-Samra
Abdul Badi Abou-Samra
Type 2 diabetes mellitus (T2DM) and obesity are syndemic and will have a significant impact on affected individuals and healthcare services worldwide. Evidence shows that T2DM remission can be achieved with significant weight loss in those who are younger with early diabetes and requiring fewer medications for glycaemic control. DIADEM-I aims to examine the impact of an intensive lifestyle intervention (ILI) using a low-energy diet (LED) meal replacement approach combined with physical activity in younger individuals with early T2DM. The planned study is an ongoing, non-blinded, pragmatic, randomised controlled, parallel-group trial examining the impact of an LED-based ILI on body weight and diabetes remission in younger (18–50 years) T2DM individuals with early diabetes (≤ 3-year duration). The ILI will be compared to usual medical care (UMC). The primary outcome will be weight loss at 12 months. Other key outcomes of interest include diabetes remission, glycaemic control, diabetes complications, cardiovascular health, physical activity, mental health, and quality of life. It is planned for the study to include 138 subjects for assessment of the primary outcome. Safety will be assessed throughout. If DIADEM-I demonstrates a clinically significant effect for younger individuals with early T2DM, it will inform clinical guidelines and services of the future for management of T2DM. ISRCTN: ISRCTN20754766 (date assigned: 7 June 2017); ClinicalTrials.gov, ID: NCT03225339 Registered on 26 June 2017.

1 July 2025 in Lupus Science & Medicine
Verified
Journal Article
Open access
PDF file
MGMiral H Gharib
Miral H Gharib
GPGeorgios Ponirakis
Georgios Ponirakis
SDSoha O M Dafaalla
Soha O M Dafaalla
HGHoda Gad
Hoda Gad
EEEinas Elgassim
Einas Elgassim
RMRAYAZ MALIK
RAYAZ MALIK
Objective: Small fibre neuropathy (SFN) is an under-recognised complication of SLE that contributes to chronic pain and reduced quality of life. We assessed the utility of corneal confocal microscopy (CCM) for identifying small fibre damage in SLE in relation to disease activity, neuropathic pain and quality of life. Methods: Participants with SLE and healthy controls underwent CCM to quantify corneal nerve fibre density (CNFD), corneal nerve branch density (CNBD), corneal nerve fibre length (CNFL), corneal nerve fibre tortuosity (CNFT), inferior whorl length (IWL), Douleur Neuropathique 4 (DN4) Score, vibration perception threshold (VPT) and sudomotor function. Results: Participants with SLE (n=59; age 38.6±9.6 years; mean Systemic Lupus Erythematosus Disease Activity Index Score 3.4±4.2) had significantly lower CNBD (41.5±21.3 vs 72.1±29.4 branches/mm², p=0.0001) and CNFL (18.5±4.3 vs 24.2±4.4 mm/mm², p=0.0001) but comparable CNFD (31.7±7.1 and 34.0±6.9 fibres/mm 2 , respectively, p=0.25), CNFT (15.0±4.0 and 14.3±3.1, respectively, p=0.55), and IWL (38.5±8.0 and 35.6±5.9 mm/mm 2 , respectively, p=0.16) compared with healthy controls (n=17). Patients with SLE had a DN4 Score of 3.5±2.5 and elevated VPT (4.1±3.3 vs 2.8±0.7 V, p<0.01) but comparable sudomotor function of the hands and feet (p=0.28–0.42). Active SLE was associated with a lower CNBD/CNFD ratio (p<0.05). Patients with SLE associated with sustained neuropathic pain (17.2%) had significantly lower CNFD, CNFL and IWL than those with transient (p<0.05–0.0001) and recurrent (p<0.05–0.01) pain but comparable VPT (p=0.27) and sudomotor function (p=0.14). Reduced CNFL was associated with bodily pain, affecting quality of life (p<0.05). Conclusion: This study demonstrates that CCM detects peripheral neurodegeneration in patients with SLE, which relates to disease activity, sustained neuropathic pain and quality of life. CCM may serve as a rapid non-invasive neuroimaging technique to identify SFN in SLE.

22 January 2024 in JMIR Preprints
Verified
Preprint
Open access
HZHadeel Zaghloul
Hadeel Zaghloul
TAThurayya Arayssi
Thurayya Arayssi
ARAmine Rakab
Amine Rakab
ALAhmed Lina
Ahmed Lina
AMArabi Maryam
Arabi Maryam
JGJamie Gray
Jamie Gray
BACKGROUND Digital health technology (DHT) is increasingly vital for managing chronic diseases, as it enables patients to actively manage their health. Such tools have been shown to improve self-management and compliance with medical advice. Nonetheless, for DHT to be fully effective, patients with chronic conditions must be digitally literate. It is essential to assess a patient's digital health literacy (DHL) and understand what factors affect it to improve resource accessibility and usability. OBJECTIVE This study aims to assess digital health literacy (DHL) in patients with diabetes (DM), hypertension (HTN), and rheumatoid arthritis (RA) through a systematic review and meta-analysis using eHEALS. The focus is to determine average DHL scores, explore influencing demographic and socioeconomic factors, and gauge the effect of DHL on disease management. This work seeks to inform future DHL enhancement strategies for better chronic disease outcomes. METHODS This systematic review was conducted in accordance with PRISMA guidelines. We conducted a systematic literature review of seven databases (PubMed, SCOPUS, Embase, ERIC, CINAHL, Library Literature and Information Science Index, and Google Scholar) from their inception till the date the search was executed- August 14, 2022. An updated search was performed in June 2023 to ensure no recent studies had been published since the initial search. The study aimed to identify studies examining DHL using the eHEALS tool in adult people with three common chronic diseases that require self-management- diabetes mellitus, hypertension, and rheumatoid arthritis. RESULTS Eight studies involving 2527 subjects were included in this review. The overall pooled mean eHEALS score was 27.03 (95% CI: 25.08-28.98), indicating high overall DHL. Stratification by disease revealed higher DHL scores for DM (27.79) and HTN (28.48) but lower scores for RA (24.74). Quality assessment indicated a high standard of included studies. Factors influencing DHL included age, education, employment, and perception of the internet as a health resource. The limited number of studies in our study precluded meta-regression analysis. CONCLUSIONS Digital health literacy (DHL) is essential for individuals with chronic conditions, empowering them to make well-informed decisions and effectively manage their health. However, due to a scarcity of studies, a comprehensive analysis of DHL determinants remains incomplete. While the internet offers a wealth of health information, unequal DHL and internet skills present barriers that must be overcome to achieve fair health outcomes. There's a clear imperative for more inclusive research to fully grasp the influence of DHL on health outcomes and to mitigate disparities, particularly in diverse populations. This will not only help in understanding DHL's role in diminishing disease rates and associated costs but also in ensuring that the benefits of digital health resources are equitably distributed. CLINICALTRIAL The study used a predefined protocol registered with prospero (CRD42023467462).


20 July 2026 in medRxiv
Verified
Preprint
Open access
PDF file
HZHadeel Zaghloul
Hadeel Zaghloul
BABatoul Arabi
Batoul Arabi
MAMinatullah Al-Ani
Minatullah Al-Ani
AAAya Abdullah
Aya Abdullah
REReel El-Masri
Reel El-Masri
TAThurayya Arayssi
Thurayya Arayssi
Whether diverse populations outside Western settings are behaviourally ready to integrate wearable-derived data into clinical care remains poorly understood. This study examines sociotechnical determinants of wearable adoption and digital health data-sharing readiness in a large, highly diverse multinational population in Qatar, a rapidly digitising health ecosystem with advanced eHealth infrastructure. We conducted a cross-sectional community-based survey of 3,004 adults across Qatar, assessing wearable device use, behavioural engagement, and willingness to integrate wearable-generated data into healthcare workflows. Multivariable logistic regression identified independent predictors of wearable adoption. Wearable device use prevalence was 34.1%. Behavioural factors were the strongest independent predictors of adoption: daily exercisers had more than four times the odds of wearable use compared with rarely active participants, and willingness to share data with healthcare providers was independently associated with adoption after full adjustment. Notably, education level was not independently associated with wearable use, suggesting that behavioural readiness outweighs traditional socioeconomic indicators as a determinant of digital health engagement. Older age (≥56 years) and African ethnicity were associated with lower adoption odds, highlighting persistent digital inequities. These findings challenge the assumption that digital health equity is primarily an education or access problem, repositioning it as a behavioural engagement challenge. Health systems scaling remote monitoring programmes should prioritise identifying behaviourally engaged subpopulations rather than relying solely on demographic targeting. Targeted digital engagement strategies addressing older adults and underrepresented ethnic groups are essential for equitable implementation of digital medicine. Author Summary: Wearable health devices - such as fitness trackers and smartwatches - are increasingly being considered not just as consumer gadgets but as tools that could help doctors monitor patients continuously between clinic visits. For this to work at a population level, we need to understand who is actually using these devices and why. Most research on this question has come from Western countries, leaving large gaps in our understanding of more diverse, rapidly developing health systems. We surveyed 3,004 adults living in Qatar, one of the most culturally and linguistically diverse countries in the world, and found that about one in three people already uses a wearable health device. More importantly, we found that the strongest predictors of who uses these devices were not education level or socioeconomic status, as is commonly assumed, but rather behavioural factors: how often someone exercises, and whether they are willing to share their device data with a doctor. Daily exercisers were more than four times as likely to use a wearable compared with rarely active individuals, and education level made no difference once we accounted for these behavioural factors. These findings suggest that efforts to expand the use of digital health tools should focus on identifying and engaging people who are already motivated about their health, rather than assuming that technology training alone will drive adoption. At the same time, older adults and African participants used wearables less often, a reminder that targeted and culturally sensitive approaches remain essential for health equity.